Wolverine Asset Management LLC Abbott Laboratories Call Options Transaction History

Wolverine Asset Management LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $1.51 Million - $1.78 Million	-15,100 Reduced 59.45%	10,300 $1.17 Million
Q2 2024 Aug 01, 2024	SELL	$100.73 - $112.44 $201,460 - $224,880	-2,000 Reduced 7.3%	25,400 $2.64 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $5.38 Million - $5.94 Million	-49,100 Reduced 64.18%	27,400 $3.11 Million
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $3.26 Million - $3.99 Million	36,100 Added 89.36%	76,500 $8.42 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.29 Million - $1.55 Million	13,500 Added 50.19%	40,400 $3.91 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $2.91 Million - $3.25 Million	-28,900 Reduced 51.79%	26,900 $2.93 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $2.59 Million - $3.04 Million	26,700 Added 91.75%	55,800 $5.65 Million
Q4 2022 Feb 01, 2023	BUY	$95.06 - $111.52 $2.73 Million - $3.2 Million	28,700 Added 7175.0%	29,100 $3.2 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $38,704 - $44,812	400 New	400 $38,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $624,780 - $697,320	13,000	13,000 $693,000

3,184

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.